Newair has been acquired by Guardian Capital Partners
Newair, a leading consumer appliances brand, has completed its recapitalization with Guardian Capital Partners.
Founded in 2001 and headquartered in Cypress, California, Newair has emerged as the fastest-growing developer of smart design, small appliance products for the discerning consumer seeking style, performance and quality. With a successful lineup of new product introductions, a growing universe of social influencers touting the merits of its offerings, and a proven and highly repeatable digital marketing strategy delivering exceptional KPIs, Newair is positioned to become the category-defining brand in high-quality appliances for the home. The company’s products can be purchased online and through major home appliance retailers.
Guardian Capital Partners is a Pennsylvania-based private equity firm specializing in the consumer space.
Oaklins’ team in Los Angeles initiated this transaction, assisted in the negotiations and served as the financial advisor to Newair.
Luke Peters
Founder and CEO, Newair
Prata med transaktionsteamet
Relaterade affärer
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Lär dig merDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Lär dig merXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Lär dig mer